Reply to: "Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything" and "More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations".
| Author | |
|---|---|
| Year of Publication |
:
2017
|
| Journal |
:
Journal of hepatology
|
| Date Published |
:
2017
|
| ISSN Number |
:
0168-8278
|
| URL |
:
https://linkinghub.elsevier.com/retrieve/pii/S0168-8278(17)32292-4
|
| DOI |
:
10.1016/j.jhep.2017.09.011
|
| Short Title |
:
J Hepatol
|
| Download citation |
